The CTSI-CN External Advisory Committee (EAC) is currently comprised of six outstanding clinical and translational scientists, including the Directors of three other CTSA hubs in the national network, a biotech company executive, and a patient advocate. Membership will be rotated every three years on a staggered basis, to ensure continuity, while providing for greater sharing of ideas and more comprehensive reviews than are generated by standing committees.
This Committee will assess the CTSI-CN’s progress in accelerating clinical and translational research and applications to improving child-health issues, as well as provide input on future directions. It will also assist the CTSI-CN in proactively positioning itself to consider new translational research initiatives and in providing an additional mechanism for enhancing linkages with other institutions in the CTSA Network.
|EAC Member||Affiliation||Leadership Role|
|Harry Selker, MD, MPH (Chair)||Tufts Medical Center||Dean, Tufts Clinical and Translational Science Institute; Tufts University, Executive Director, Institute for Clinical Research and Health Policy Studies|
|Edward Connor, MD, MBE, FAAP||Institute for Advanced Clinical Trials for Children (I-ACT)||
Chairman, Board of Directors and President, I-ACT
|Daniel Ford, MD||Johns Hopkins School of Medicine||Director, Institute for Clinical and Translational Research; Vice Dean for Clinical Investigation|
|Paul Harris, PhD||Vanderbilt University||Associate Professor of Biomedical Informatics; Director, Office of Research Informatics, Institute for Clinical and Translational Research|
|James Heubi, MD||Cincinnati Children's Hospital||Associate Dean for Clinical and Translational Research; Co-Director Center for Clinical and Translational Science and Training|
|Carol Horowitz, MD||Icahn School of Medicine at Mt. Sinai||Co-Director, Center for Health Equity and Community Engaged Research, ConduITS|
|Jana Monaco||Advocate||Chair, CNHS Patient and Family Advisory Council|